Skip to search formSkip to main contentSkip to account menu

racotumomab

Known as: Anti-P3 Antibody Idiotype Monoclonal Antibody 1E10, MoAb 1E10 
An anti-idiotype murine monoclonal antibody (MoAb) specific to P3 MoAb with anti-metastatic effect. Racotumomab binds to the idiotype region of P3… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Monoclonal Antibodies
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer
Despite extensive clinical research in non-small cell lung cancer (NSCLC), overall survival is still poor. Racotumomab-alum is… 
2014
2014
advanced non-small-cell-lung cancer patients racotumomab-alum vaccine as switch maintenance therapy in A randomized , multicenter , placebo-controlled clinical trial of
2013
2013
Seguridad del Racotumomab en el tratamiento de pacientes con cáncer de pulmón de células no pequeñas
En Cuba, el cancer de pulmon es el segundo en incidencia y el primero en mortalidad. Por tanto, se necesita identificar nuevas… 
2012
2012
Challenges in development of an anti-idiotypic cancer vaccine
2012
2012
Abstract LB-108: Racotumomab antitumor activity in the murine model of non small cell lung carcinoma 3LL is related with the level of expression on NGcGM3
N-Glycolylneuraminic acid (NGc) is a sialic acid molecule found in most mammalian cells. It is usually found as terminal…